Veterinary Medicines

Tsefalen 1000 mg film-coated tablets for dogs

Authorised
  • Cefalexin
Download as PDF

Product identification

Medicine name:
Tsefalen 1000 mg film-coated tablets for dogs
Tsefalen 1000 mg filmtabletta kutyák számára
Active substance:
  • Cefalexin
Target species:
  • Dog
Route of administration:
  • Oral use

Product details

Active substance and strength:
  • Cefalexin
    1000.00
    milligram(s)
    /
    1.00
    Tablet
Pharmaceutical form:
  • Film-coated tablet
Withdrawal period by route of administration:
  • Oral use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ01DB01
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Hungary
Package description:
  • Carton box containing 13 PVC/Aluminium blister pack of 8 tablets, with a total of 104 tablets
  • Carton box containing 4 PVC/Aluminium blister pack of 8 tablets, with a total of 32 tablets
  • Carton box containing 1 PVC/Aluminium blister pack of 8 tablets

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Nextmune Italy S.r.l.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Acs Dobfar S.p.A.
Responsible authority:
  • Directorate Of Veterinary Medicinal Products
Authorisation number:
  • 3200/X/12 NÉBIH ÁTI
Date of authorisation status change:
Reference member state:
  • Italy
Procedure number:
  • IT/V/0125/002
Concerned member states:
  • Austria
  • Belgium
  • Bulgaria
  • Cyprus
  • Czechia
  • Denmark
  • Estonia
  • Finland
  • France
  • Germany
  • Greece
  • Hungary
  • Ireland
  • Latvia
  • Liechtenstein
  • Lithuania
  • Luxembourg
  • Malta
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."